US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

HROW

Harrow (HROW)

Harrow Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:HROW

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/15	20 : 00	Business Wire	Harrow to Present at Two Investor Conferences in May	NASDAQ:HROW	Harrow Inc
2024/05/14	05 : 01	Business Wire	Harrow Announces First Quarter 2024 Financial Results	NASDAQ:HROW	Harrow Inc
2024/05/13	20 : 00	Business Wire	Harrow Names Greg DiPasquale as Senior Vice President, Head of Commercial	NASDAQ:HROW	Harrow Inc
2024/04/25	20 : 00	Business Wire	Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024	NASDAQ:HROW	Harrow Inc
2024/04/02	21 : 16	Business Wire	Melt Pharmaceuticals Closes $24 Million Series B Preferred Stock Financing	NASDAQ:HROW	Harrow Inc
2024/03/20	20 : 15	IH Market News	JPMorgan boosts dividends, Chipotle unveils 50:1 stock split, and Latest News	NASDAQ:HROW	Harrow Inc
2024/03/20	06 : 45	Business Wire	Harrow Announces Fourth Quarter and Year-End 2023 Financial Results	NASDAQ:HROW	Harrow Inc
2024/03/19	20 : 27	IH Market News	US Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices Retreat	NASDAQ:HROW	Harrow Inc
2024/03/06	20 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HROW	Harrow Inc
2024/03/05	21 : 00	Business Wire	Harrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024	NASDAQ:HROW	Harrow Inc
2024/02/22	09 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HROW	Harrow Inc
2024/02/22	09 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HROW	Harrow Inc
2024/02/16	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HROW	Harrow Inc
2024/02/16	06 : 01	Business Wire	Harrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical Products	NASDAQ:HROW	Harrow Inc
2024/02/10	06 : 05	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:HROW	Harrow Inc
2024/02/08	21 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HROW	Harrow Inc
2024/01/30	06 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HROW	Harrow Inc
2024/01/30	05 : 26	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:HROW	Harrow Inc
2024/01/29	21 : 00	Business Wire	Harrow Announces New Appointments to its Board of Directors	NASDAQ:HROW	Harrow Inc
2024/01/11	21 : 00	Business Wire	Harrow Announces Availability of VEVYE® (Cyclosporine Ophthalmic Solution) 0.1%, the First and Only Cyclosporine-Based Product Indicated for Treating Both Signs and Symptoms of Dry Eye Disease	NASDAQ:HROW	Harrow Inc
2024/01/10	00 : 16	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:HROW	Harrow Inc
2024/01/03	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HROW	Harrow Inc
2024/01/03	21 : 15	Business Wire	Melt Pharmaceuticals Provides Corporate Update	NASDAQ:HROW	Harrow Inc
2024/01/03	21 : 00	Business Wire	Harrow Partners with Leading Healthcare Market Access Technology Platforms	NASDAQ:HROW	Harrow Inc
2023/11/29	21 : 00	Business Wire	Harrow Completes Transfer of the TRIESENCE® New Drug Application	NASDAQ:HROW	Harrow Inc
2023/11/20	21 : 00	Business Wire	Harrow to Present at Two Investor Conferences in November	NASDAQ:HROW	Harrow Inc
2023/11/17	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HROW	Harrow Inc
2023/11/15	09 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HROW	Harrow Inc
2023/11/14	06 : 38	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HROW	Harrow Inc
2023/11/14	06 : 34	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HROW	Harrow Inc

Showing the most relevant articles for your search:NASDAQ:HROW

1 2 3 4 5 6 7 8 9 10 次へ >>

Vontobel Financial Produ...

Westpac Banking

Bund Lug34 Eur 4,75

BNP Paribas Issuance

BNP Paribas Issuance

Eaton Vance Total Return...

Vontobel Financial Produ...

BNP Paribas Issuance

BNP Paribas Issuance

Societe Generale Effekten

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約